These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
550 related items for PubMed ID: 16872127
1. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia]. MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127 [No Abstract] [Full Text] [Related]
2. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. Holcomb K, Weinberg JM. J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651 [Abstract] [Full Text] [Related]
3. [Two U.S. experts discuss the consequences of the "Shingles Prevention Study". Is senior vaccination worthwhile in the practice?]. MMW Fortschr Med; 2006 Oct; Spec no.1():16. PubMed ID: 16872128 [No Abstract] [Full Text] [Related]
4. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia. Betts RF. J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866 [Abstract] [Full Text] [Related]
5. Vaccination: a new option to reduce the burden of herpes zoster. Mick G. Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716 [Abstract] [Full Text] [Related]
6. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications]. Marino MG, Bagnato B, Torella I, Franco E. Ig Sanita Pubbl; 2009 Mar; 65(3):299-311. PubMed ID: 19629155 [Abstract] [Full Text] [Related]
7. [Herpes zoster and postherpetic neuralgia: advantages of the vaccination]. Cañada JL. Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():19-21. PubMed ID: 20084344 [No Abstract] [Full Text] [Related]
8. Shingles vaccine: who should get it? Johnson AM. S D Med; 2006 Aug; 59(8):349-50. PubMed ID: 16941852 [No Abstract] [Full Text] [Related]
9. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Pellissier JM, Brisson M, Levin MJ. Vaccine; 2007 Nov 28; 25(49):8326-37. PubMed ID: 17980938 [Abstract] [Full Text] [Related]
10. Herpes zoster vaccine (Zostavax). Med Lett Drugs Ther; 2006 Sep 11; 48(1243):73-4. PubMed ID: 16977285 [Abstract] [Full Text] [Related]
11. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Sanford M, Keating GM. Drugs Aging; 2010 Feb 01; 27(2):159-76. PubMed ID: 20104941 [Abstract] [Full Text] [Related]
12. [Does vaccination prevent postherpetic neuralgia?]. Krome S. Dtsch Med Wochenschr; 2011 Jun 01; 136(23):1240. PubMed ID: 21630167 [No Abstract] [Full Text] [Related]
13. Prevention of herpes zoster and its painful and debilitating complications. Johnson R, McElhaney J, Pedalino B, Levin M. Int J Infect Dis; 2007 Nov 01; 11 Suppl 2():S43-8. PubMed ID: 18162246 [Abstract] [Full Text] [Related]
14. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Hornberger J, Robertus K. Ann Intern Med; 2006 Sep 05; 145(5):317-25. PubMed ID: 16954357 [Abstract] [Full Text] [Related]
16. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. Tseng HF, Lewin B, Hales CM, Sy LS, Harpaz R, Bialek S, Luo Y, Jacobsen SJ, Reddy K, Huang PY, Zhang J, Anand S, Bauer EM, Chang J, Tartof SY. J Infect Dis; 2015 Oct 15; 212(8):1222-31. PubMed ID: 26038400 [Abstract] [Full Text] [Related]
17. A GVF Zoster Workshop. Johnson RW. J Clin Virol; 2010 May 15; 48 Suppl 1():S1. PubMed ID: 20510261 [No Abstract] [Full Text] [Related]
18. Vaccination to prevent herpes zoster and postherpetic neuralgia. Oxman MN. Hum Vaccin; 2007 May 15; 3(2):64-8. PubMed ID: 17299270 [No Abstract] [Full Text] [Related]